Eventide Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-422,856	Closed	-$4.57M	–	212
2024 Q3	$4.57M	Sell	422,856 -458,301	-52%	-$4.95M	0.08%	139
2024 Q2	$18.5M	Buy	881,157 +105,043	+14%	+$2.2M	0.32%	94
2024 Q1	$24.7M	Buy	+776,114	New	+$24.7M	0.39%	79